TAK 603/A 165646 IN PATIENTS W/ CROHNS DISEASE

TAK 603/A 165646 用于克罗恩病患者

• 批准号: 6423261
• 负责人: KIM L ISAACS
• 金额: $ 29.46万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-12-01 至 2001-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6423261
• 关键词: Crohn's disease; antirheumatic agents; antiulcer drug; clinical research; drug screening /evaluation; gastrointestinal agents; gastrointestinal disorder chemotherapy; human subject; human therapy evaluation; immunomodulators; quinoline; Crohn's disease; antirheumatic agents; antiulcer drug; clinical research; drug screening /evaluation; gastrointestinal agents; gastrointestinal disorder chemotherapy; human subject; human therapy evaluation; immunomodulators; quinoline

暂无数据